GENEVA, Aug. 4 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/IB2025/050828) for "PEGYLATED IL-2 FOR SUPPRESSING ADAPTIVE IMMUNE RESPONSE TO GENE THERAPY" on Jan 24, 2025. With publication no. WO/2025/158385, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHOUDHURY, Sourav Roy (c/o Sanofi450 Water StreetCambridge, Massachusetts 02141), MOTWANI, Mona (c/o Sanofi450 Water StreetCambridge, Massachusetts 02141), MUELLER, Christian (c/o Sanofi450 Water StreetCambridge, ...